Strategic Wealth Investment Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,064
Closed -$228K 139
2022
Q4
$228K Buy
+5,064
New +$243K 0.05% 110
2022
Q3
Sell
-4,049
Closed -$212K 121
2022
Q2
$212K Buy
+4,049
New +$206K 0.05% 125
2022
Q1
Sell
-4,181
Closed -$247K 110
2021
Q4
$247K Buy
+4,181
New +$207K 0.06% 75

Other funds holding PFE

Strategic Wealth Investment Group's PFE Position: Q1 2023 in Review

Strategic Wealth Investment Group sold out of Pfizer (PFE) in Q1 2023, closing a stake of 5,064 shares — an estimated $228K sold.

Strategic Wealth Investment Group first reported a position in PFE in Q4 2021 and held it in 3 quarters. The position peaked at $247K in Q4 2021. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Strategic Wealth Investment Group reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Strategic Wealth Investment Group sold 5,064 Pfizer shares in Q1 2023, an estimated $228K.
  • Strategic Wealth Investment Group first reported a position in Pfizer in Q4 2021 and held it in 3 quarters.
  • Strategic Wealth Investment Group's Pfizer position peaked at $247K in Q4 2021.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Strategic Wealth Investment Group's 13F filing for Q1 2023, filed 20 Apr 2023.